OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool
Mike Sharland, Sumanth Gandra, Benedikt Huttner, et al.
The Lancet Infectious Diseases (2019) Vol. 19, Iss. 12, pp. 1278-1280
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Antibiotics in the clinical pipeline in October 2019
Mark S. Butler, David L. Paterson
The Journal of Antibiotics (2020) Vol. 73, Iss. 6, pp. 329-364
Open Access | Times Cited: 237

Antibiotic prescription practices in primary care in low- and middle-income countries: A systematic review and meta-analysis
Giorgia Sulis, Pierrick Adam, Vaidehi Nafade, et al.
PLoS Medicine (2020) Vol. 17, Iss. 6, pp. e1003139-e1003139
Open Access | Times Cited: 200

Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries
Brian Godman, Abiodun Egwuenu, Mainul Haque, et al.
Life (2021) Vol. 11, Iss. 6, pp. 528-528
Open Access | Times Cited: 179

The importance of antimicrobial resistance in medical mycology
Neil A. R. Gow, Carolyn Johnson, Judith Berman, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 147

Optimizing antibiotic therapies to reduce the risk of bacterial resistance
Stefano Bassetti, Sarah Tschudin‐Sutter, Adrian Egli, et al.
European Journal of Internal Medicine (2022) Vol. 99, pp. 7-12
Open Access | Times Cited: 106

Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis
Giorgia Sulis, Brice Batomen, Anita Kotwani, et al.
PLoS Medicine (2021) Vol. 18, Iss. 7, pp. e1003682-e1003682
Open Access | Times Cited: 103

Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries
Ines Pauwels, Ann Versporten, Nico Drapier, et al.
Journal of Antimicrobial Chemotherapy (2021) Vol. 76, Iss. 6, pp. 1614-1624
Open Access | Times Cited: 102

Exposure to World Health Organization's AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis
Giorgia Sulis, Sena Sayood, Shashi Katukoori, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 9, pp. 1193-1202
Open Access | Times Cited: 88

Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future
Brian Godman, Abiodun Egwuenu, Evelyn Wesangula, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 8, pp. 1089-1111
Open Access | Times Cited: 81

Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance
Tiyani Milta Sono, Eugene Vernyuy Yeika, Aislinn Cook, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 10, pp. 1025-1055
Open Access | Times Cited: 41

WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections
Lorenzo Moja, Veronica Zanichelli, Dominik Mertz, et al.
Clinical Microbiology and Infection (2024) Vol. 30, pp. S1-S51
Open Access | Times Cited: 34

Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies
Robby Nieuwlaat, Lawrence Mbuagbaw, Dominik Mertz, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 9, pp. 1657-1659
Open Access | Times Cited: 135

Antibiotic overuse in the primary health care setting: a secondary data analysis of standardised patient studies from India, China and Kenya
Giorgia Sulis, Benjamin Daniels, Ada Kwan, et al.
BMJ Global Health (2020) Vol. 5, Iss. 9, pp. e003393-e003393
Open Access | Times Cited: 89

The ecosystem of health decision making: from fragmentation to synergy
Holger J. Schünemann, Marge Reinap, Thomas Piggott, et al.
The Lancet Public Health (2022) Vol. 7, Iss. 4, pp. e378-e390
Open Access | Times Cited: 65

Key Issues Surrounding Appropriate Antibiotic Use for Prevention of Surgical Site Infections in Low- and Middle-Income Countries: A Narrative Review and the Implications
Julius Chacha Mwita, Olayinka O. Ogunleye, Adesola Olalekan, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 515-530
Open Access | Times Cited: 61

Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future
Zikria Saleem, Brian Godman, Aislinn Cook, et al.
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1824-1824
Open Access | Times Cited: 59

Cannabis sativa CBD Extract Shows Promising Antibacterial Activity against Salmonella typhimurium and S. newington
Logan Gildea, Joseph Ayariga, Olufemi S. Ajayi, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2669-2669
Open Access | Times Cited: 37

Antimicrobial stewardship capacity and antibiotic utilisation practices in the Cape Coast Teaching Hospital, Ghana: A point prevalence survey study
Elizabeth Agyare, Joseph Elikem Efui Acolatse, Mavis Puopelle Dakorah, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0297626-e0297626
Open Access | Times Cited: 12

A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications
Phumzile Skosana, Natalie Schellack, Brian Godman, et al.
Expert Review of Anti-infective Therapy (2021) Vol. 19, Iss. 10, pp. 1353-1366
Open Access | Times Cited: 46

An Assessment of the Impact of Coronavirus Disease (COVID-19) Pandemic on National Antimicrobial Consumption in Jordan
Sayer Al‐Azzam, Nizar M. Mhaidat, Hayaa Abdallah Banat, et al.
Antibiotics (2021) Vol. 10, Iss. 6, pp. 690-690
Open Access | Times Cited: 46

Predatory bacteria as living antibiotics – where are we now?
Robert J. Atterbury, Jess Tyson
Microbiology (2021) Vol. 167, Iss. 1
Open Access | Times Cited: 43

Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications from ESAC-Net and WHO Europe
Jane Robertson, Vera Vlahović‐Palčevski, Kotoji Iwamoto, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 43

Page 1 - Next Page

Scroll to top